Amynas

Foundation date

23/12/2019

Sector

#Medical Technology

Subsector

Amynas’ lead candidate product is a bio-envelope made of electrospun nanofibers designed to promote healthy tissue growth around the implant (anti-inflammatory and anti-scarring) and reduce the infection rate, resulting in fewer re-admission rates for post-surgical complications.

Upcoming events

Latest news

  • Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease

    Friday December 6th 2024

  • VUB and VIB launch new Bio Incubator Brussels on VUB campus

    Friday December 6th 2024

  • Does the menstrual cycle influence the effect of chemotherapy?

    Thursday December 5th 2024